Correspondingly, in colorectal cancer, especially in the angiogenic CMS4 subtype, anti-MCAM antibodies inhibited tumor growth and angiogenesis by disrupting vascular signaling [177]. The gene discussed is MCAM; the disease is colorectal cancer.